Jimmy Kimmel returns to air, but not everywhere as local ABC-affiliates opt out

France 24Wednesday, September 24, 2025 at 9:38:15 AM
Jimmy Kimmel returns to air, but not everywhere as local ABC-affiliates opt out
Jimmy Kimmel made his return to the airwaves after a suspension related to comments on Charlie Kirk's assassination, but not all viewers will see him. Some local ABC affiliates, including Sinclair and Nexstar Media Group, have chosen to replace his show with different programming, reflecting pressures from the Trump administration. This situation highlights the complex interplay between media, politics, and local broadcasting decisions. Additionally, UBS has resolved its long-standing tax evasion issues in France, marking a significant development in international finance.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Joe Rogan comes to Jimmy Kimmel’s defense, calling for America to be a ‘community’ with a ‘strong social safety net’—and free speech
PositiveFinancial Markets
Joe Rogan has stepped up to defend Jimmy Kimmel, emphasizing the importance of free speech and the need for a strong social safety net in America. Rogan believes that the government should not interfere with what comedians say, highlighting the value of open dialogue in comedy. This stance resonates with many who feel that artistic expression should be protected, making it a significant moment in the ongoing conversation about freedom of speech and community support.
Joe Rogan comes to Jimmy Kimmel’s defense, calling for America to be a ‘community’ with a ‘strong social safety net’—and free speech
PositiveFinancial Markets
Joe Rogan has stepped up to defend Jimmy Kimmel, emphasizing the importance of free speech and the need for a strong social safety net in America. Rogan believes that the government should not interfere with what comedians say, highlighting the value of open dialogue in comedy. This stance resonates with many who feel that artistic expression should be protected, making it a significant moment in the ongoing conversation about freedom of speech and community support.
Teva Pharma stock price target raised to $26 by UBS on Austedo outlook
PositiveFinancial Markets
Teva Pharmaceuticals has received a boost as UBS raised its stock price target to $26, driven by a positive outlook on its Austedo medication. This adjustment reflects confidence in Teva's growth potential and the effectiveness of Austedo in treating movement disorders. Investors are likely to view this news favorably, as it suggests a promising future for the company and its product lineup.
Teva Pharma stock price target raised to $26 by UBS on Austedo outlook
PositiveFinancial Markets
Teva Pharmaceuticals has received a boost as UBS raised its stock price target to $26, driven by a positive outlook on its Austedo medication. This adjustment reflects confidence in Teva's growth potential and the effectiveness of Austedo in treating movement disorders. Investors are likely to view this news favorably, as it suggests a promising future for the company and its product lineup.
UBS maintains Crane NXT stock rating at Neutral despite currency print order
NeutralFinancial Markets
UBS has decided to maintain its neutral rating on Crane NXT's stock, even in light of recent developments regarding currency print orders. This decision reflects UBS's cautious approach to the stock, suggesting that while there may be potential, the overall market conditions and company performance warrant a wait-and-see attitude. Investors should take note of this rating as it indicates a balanced perspective on the company's future prospects.
UBS maintains Crane NXT stock rating at Neutral despite currency print order
NeutralFinancial Markets
UBS has decided to maintain its neutral rating on Crane NXT's stock, even in light of recent developments regarding currency print orders. This decision reflects UBS's cautious approach to the stock, suggesting that while there may be potential, the overall market conditions and company performance warrant a wait-and-see attitude. Investors should take note of this rating as it indicates a balanced perspective on the company's future prospects.
UBS lowers DraftKings stock price target to $56 from $58, maintains Buy rating
NeutralFinancial Markets
UBS has adjusted its price target for DraftKings' stock from $58 to $56 while maintaining a Buy rating. This slight decrease reflects UBS's analysis of the current market conditions and DraftKings' performance. Investors should pay attention to this adjustment as it may influence trading decisions and perceptions of the company's growth potential.
UBS lowers DraftKings stock price target to $56 from $58, maintains Buy rating
NeutralFinancial Markets
UBS has adjusted its price target for DraftKings' stock from $58 to $56 while maintaining a Buy rating. This slight decrease reflects UBS's analysis of the current market conditions and DraftKings' performance. Investors should pay attention to this adjustment as it may influence trading decisions and perceptions of the company's growth potential.
Micron Technology price target raised to $195 from $185 at UBS
PositiveFinancial Markets
Micron Technology has received a price target increase from UBS, now set at $195, up from the previous $185. This adjustment reflects growing confidence in Micron's performance and potential in the semiconductor market, which is crucial for investors looking for promising opportunities in technology stocks.
Micron Technology price target raised to $195 from $185 at UBS
PositiveFinancial Markets
Micron Technology has received a price target increase from UBS, now set at $195, up from the previous $185. This adjustment reflects growing confidence in Micron's performance and potential in the semiconductor market, which is crucial for investors looking for promising opportunities in technology stocks.
Madrigal Pharmaceuticals stock maintains Buy rating at UBS on strong MASH market outlook
PositiveFinancial Markets
Madrigal Pharmaceuticals has received a Buy rating from UBS, reflecting strong confidence in the MASH market outlook. This positive assessment is significant as it highlights the potential growth and profitability of Madrigal's products, which could attract more investors and boost stock performance. The MASH market's promising future suggests that Madrigal is well-positioned to capitalize on emerging opportunities, making it an exciting time for stakeholders.
Madrigal Pharmaceuticals stock maintains Buy rating at UBS on strong MASH market outlook
PositiveFinancial Markets
Madrigal Pharmaceuticals has received a Buy rating from UBS, reflecting strong confidence in the MASH market outlook. This positive assessment is significant as it highlights the potential growth and profitability of Madrigal's products, which could attract more investors and boost stock performance. The MASH market's promising future suggests that Madrigal is well-positioned to capitalize on emerging opportunities, making it an exciting time for stakeholders.
Latest from Financial Markets
The Pros and Cons of a Private Student Loan
NeutralFinancial Markets
The article explores the pros and cons of private student loans compared to federal options, highlighting key differences such as interest rates and repayment terms. Understanding these distinctions is crucial for students and families making financial decisions about education funding, as it can significantly impact their long-term financial health.
Bessent Says U.S. Talking With Argentina About $20 Billion in Aid
PositiveFinancial Markets
U.S. officials are in discussions with Argentina regarding a substantial $20 billion aid package, a move that could provide much-needed support as the South American nation grapples with a market run on its peso and uncertainty about its economic future. This potential assistance is significant not only for stabilizing Argentina's economy but also for strengthening U.S.-Latin American relations during a challenging time.
80% of millennials and Gen Z who used AI for financial advice say it helped—but it’s not without risk: over half made a bad decision as a result
PositiveFinancial Markets
A recent study reveals that 80% of millennials and Gen Z who sought financial advice from AI found it beneficial, marking a significant shift in how young people manage their finances. This trend highlights the growing reliance on technology for financial decisions, as traditional sources like parents are being replaced by AI tools. However, the study also warns that over half of these users made poor decisions based on the advice they received, emphasizing the need for caution and critical thinking when using AI for financial guidance.
Joe Rogan comes to Jimmy Kimmel’s defense, calling for America to be a ‘community’ with a ‘strong social safety net’—and free speech
PositiveFinancial Markets
Joe Rogan has stepped up to defend Jimmy Kimmel, emphasizing the importance of free speech and the need for a strong social safety net in America. Rogan believes that the government should not interfere with what comedians say, highlighting the value of open dialogue in comedy. This stance resonates with many who feel that artistic expression should be protected, making it a significant moment in the ongoing conversation about freedom of speech and community support.
Street Talk: Is this markert rally sustainable?
NeutralFinancial Markets
In a recent discussion, Rebecca Walser, CEO of Walter Wealth Management, shared insights on the current bullish market rally and the potential for a bearish turn. This analysis is crucial for investors as it helps them navigate market fluctuations and make informed decisions about their portfolios.
One killed and two injured in shooting at ICE office in Dallas, Texas
NegativeFinancial Markets
A tragic shooting incident at an ICE office in Dallas, Texas, has left one person dead and two others injured. Homeland Security Secretary Kristi Noem stated that the motive behind the attack remains unknown. This event raises significant concerns about safety and security at federal facilities, highlighting the ongoing challenges faced by law enforcement and the need for enhanced protective measures.